FDA – September, 2, 2020 - According to a news report on Raps.org, the US Food and Drug Administration (FDA) addressed the issue of nitrosamine contamination in two tuberculosis antibiotic medications, which are critically needed to treat the potentially fatal disease.  In a recent report, the FDA clarified how the agency would … [Read more...] about Rifampin, Rifapentine Nitrosamine Cancer Lawsuit Lawyers